Treatment of acute myelogenous leukemia
Meisenberg, B.
New England Journal of Medicine 332(25): 1718; Author Reply 1718-1719
1995
ISSN/ISBN: 0028-4793 PMID: 7619165 Document Number: 448002
Document emailed within 1 workday
Related Documents
Estey, E.H. 2002: Treatment of acute myelogenous leukemia Oncology 16(3): 343-352; 355-356; Discussion 357 362 365-366Ghaddar, H.; Anderlini, P.; Estey, E. 1995: Treatment of acute myelogenous leukemia New England Journal of Medicine 332(25): 1717-1718; Author Reply 1718-1719
Advani, A.S. 2005: C-kit as a target in the treatment of acute myelogenous leukemia Current Hematology Reports 4(1): 51-58
Dohy, H.; Kyo, T. 1989: Progress in the treatment of acute myelogenous leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(5): 1976-1981
Champlin, R.E.; Gajewski, J.L.; Golde, D.W. 1989: Treatment of acute myelogenous leukemia in the elderly Seminars in Oncology 16(1): 51-56
Tangen, J.M.; Berentsen, S.; Dahl, I.M.; Ly, B.; Myrvang, B. 1999: Empirical antibiotic treatment of patients with acute myelogenous leukemia Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 119(1): 35-38
Fülle, H.H. 1977: Induction and maintenance treatment of acute myelogenous leukemia in adults by sequential use of combination chemotherapy Medizinische Klinik 72(15): 642-649
Alsabti, E.A.; Taleb, A.M.; Raji, H.M.; Kalil, O.Z.; Saleh, K.A. 1979: Clinical trials in vaccination with leukemia associated antigens in acute myelogenous leukemia Japanese Journal of Experimental Medicine 49(3): 157-168
Santos, G.W. 1988: Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia Cancer Detection and Prevention 12(1-6): 589-596
Dhingra, K.; Talpaz, M.; Kantarjian, H.; Ku, S.; Rothberg, J.; Gutterman, J.U.; Kurzrock, R. 1991: Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression Leukemia 5(3): 191-195
Shumak, K.H.; Baker, M.A.; Taub, R.N.; Coleman, M.S. 1980: Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 40(11): 4048-4052
Anderson, J.K.; Moore, J.O.; Metzgar, R.S. 1979: Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis Cancer Research 39(12): 4810-4815
Ghaddar, H.M.; Plunkett, W.; Kantarjian, H.M.; Pierce, S.; Freireich, E.J.; Keating, M.J.; Estey, E.H. 1994: Long-term results following treatment of newly-diagnosed acute myelogenous leukemia with continuous-infusion high-dose cytosine arabinoside Leukemia 8(8): 1269-1274
Mittal, R.R.; Kullar, J.; Sethi, P.S. 2000: Skin changes in acute myelogenous leukemia Indian Journal of Dermatology Venereology and Leprology 66(5): 266-267
Gale, R.P.; Foon, K.A. 1987: Therapy of acute myelogenous leukemia Seminars in Hematology 24(1): 40-54
Lie, S.O. 1974: Acute myelogenous leukemia in children Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 94(32): 2232-2234
Gale, R.P.; Butturini, A. 1991: Strategies for acute myelogenous leukemia Bone Marrow Transplantation 7(Suppl 2): 58
Mohanakumar, T.; Russell, E.C.; Metzgar, R.S.; Dunn, N.; Phibbs, M.; McWilliams, N.B.; Maurer, H.M. 1979: Human acute myelogenous leukemia antigens defined by simian antisera: evidence for leukemia-associated antigens distinct from immune response-associated alloantigens Journal of the National Cancer Institute 62(5): 1163-1167
Suciu, S.; Solbu, G.; Zittoun, R.; Hayat, M.; Willemze, R.; de Witte, T.; Mandelli, F. 1991: Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA Bone Marrow Transplantation 7(Suppl 2): 34
Ness, P.M.; Perkins, H.A. 1979: Therapeutic complications in acute myelogenous leukemia New England Journal of Medicine 301(10): 557